Characterization of Butyrate-Resistant Colorectal Cancer Cell Lines and the Cytotoxicity of Anticancer Drugs against These Cells

被引:3
|
作者
Nittayaboon, Kesara [1 ]
Leetanaporn, Kittinun [1 ]
Sangkhathat, Surasak [1 ]
Roytrakul, Sittiruk [2 ]
Navakanitworakul, Raphatphorn [1 ]
机构
[1] Prince Songkla Univ, Fac Med, Dept Biomed Sci & Biomed Engn, Hat Yai 90110, Songkhla, Thailand
[2] Natl Ctr Genet Engn & Biotechnol BIOTEC, Funct Ingredients & Food Innovat Res Grp, Natl Sci & Technol Dev Agcy, Pathum Thani 12120, Thailand
关键词
HUMAN COLON-CANCER; GUT MICROBIOTA; ACQUISITION; MECHANISMS; METFORMIN; OUTCOMES; STRESS; ARREST; PCR;
D O I
10.1155/2022/6565300
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Colorectal cancer (CRC) is the third most common cancer worldwide. The gut microbiota plays a critical role in homeostasis and carcinogenesis. Butyrate, a short-chain fatty acid produced by the gut microbiota, plays a role in intestinal homeostasis and acts as an anticancer agent by inhibiting growth and inducing apoptosis. However, microbiota studies have revealed an abnormally high abundance of butyrate-producing bacteria in patients with CRC and indicated that it leads to chemoresistance. We characterized butyrate resistance in HCT-116 and PMF-K014 CRC cells after treatment with a maximum butyrate concentration of 3.2 mM. The 50% inhibitory concentration of butyrate was increased in butyrate-resistant (BR) cells compared with that in parental (PT) cells. The mechanism of butyrate resistance was initially investigated by determining the expression of butyrate influx- and drug efflux-related genes. We found the increased expression of influx- and efflux-related genes in BR cells compared with that in PT cells. Proteomic data showed both identical and different proteins in PT and BR cells. Further analysis revealed the crossresistance of HCT-116 cells to metformin and oxaliplatin and that of PMF-K014 cells to 5-fluorouracil. Our findings suggest that the acquisition of butyrate resistance induces the development of chemoresistance in CRC cells, which may play an important role in CRC development, treatment, and metastasis.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Butyrate-resistant colorectal cancer cells are also resistant to sulindac sulfide and sulfone.
    Chai, F
    Young, GP
    Zalewski, PD
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A1383 - A1383
  • [2] Cytotoxic effect of metformin on butyrate-resistant PMF-K014 colorectal cancer spheroid cells
    Nittayaboon, Kesara
    Leetanaporn, Kittinun
    Sangkhathat, Surasak
    Roytrakul, Sittirak
    Navakanitworakul, Raphatphorn
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 151
  • [3] Proteomic Analysis of Butyrate-Resistant Colorectal Cancer-Derived Exosomes Reveals Potential Resistance to Anti-Cancer Drugs
    Nittayaboon, Kesara
    Leetanaporn, Kittinun
    Sangkhathat, Surasak
    Roytrakul, Sittiruk
    Navakanitworakul, Raphatphorn
    [J]. DISCOVERY MEDICINE, 2024, 36 (185) : 1306 - 1315
  • [4] Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell lines
    Viale, M
    Pastrone, I
    Pellecchia, C
    Vannozzi, MO
    Cafaggi, S
    Esposito, M
    [J]. ANTI-CANCER DRUGS, 1998, 9 (05) : 457 - 463
  • [5] The effects of chemotherapy drugs on apoptosis and bcl-2 and bax expression in HeLa cells and a butyrate-resistant clone
    Robinson, KB
    Richard, C
    Th'ng, J
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 273A - 273A
  • [6] Enhancing the effect of anticancer drugs against the colorectal cancer cell line with electroporation
    Kambe, M
    Arita, D
    Kikuchi, H
    Funato, T
    Tezuka, F
    Gamo, M
    Murakawa, Y
    Kanamaru, R
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 180 (02): : 161 - 171
  • [7] Different Schedule-Dependent Effects of Epigenetic Modifiers on Cytotoxicity by Anticancer Drugs in Colorectal Cancer Cells
    Hosokawa, Mika
    Tanaka, Shota
    Ueda, Kumiko
    Iwakawa, Seigo
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (12) : 2199 - 2204
  • [8] Cerivastatin enhances the cytotoxicity of 5-fluorouracil on chemosensitive and resistant colorectal cancer cell lines
    Wang, WG
    Collie-Duguid, E
    Cassidy, J
    [J]. FEBS LETTERS, 2002, 531 (03) : 415 - 420
  • [9] Anticancer activity and paraptosis induction of novel bipyridine-silver(I) compounds against resistant colorectal and ovarian cancer cell lines
    Stefanelli, Alessia
    Teixeira, Ricardo G.
    Pilon, Adhan
    Warmers, Rebecca
    Ott, Ingo
    Kowol, Christian R.
    Brozovic, Anamaria
    Tomaz, Ana Isabel
    Valente, Andreia
    Heffeter, Petra
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [10] Anticancer effects of fucoxanthin and fucoxanthinol on colorectal cancer cell lines and colorectal cancer tissues
    Takahashi, Kazuto
    Hosokawa, Masashi
    Kasajima, Hiroyuki
    Hatanaka, Kazuteru
    Kudo, Kazuhiro
    Shimoyama, Norihiko
    Miyashita, Kazuo
    [J]. ONCOLOGY LETTERS, 2015, 10 (03) : 1463 - 1467